当前位置:Public Access >页面
Chinese/English
Exploratory study of Lenvatinib combined with Gefitinib in the treatment of Lenvatinib resistant intermediate and advanced liver cancer
Filter Options
Patient No. Patient Name Patient Gender
Sitting Education Date of enrollment FromTo
       More Options
Patient No Gender Date of enrollment Sitting Creater Operate
3 Man 2020-02-07

OPD

Dingmin
2 Man 2020-01-14

Other

Dingmin
1 Man 2020-02-05

Other

Dingmin